Jayson and Jones, 197I) , and with this in mind the present study differentiates rheumatoid episcieritis and scleritis from non-rheumatoid episcleritis and scleritis according to the criteria for 'classical' or 'definite' rheumatoid arthritis (Ropes, Bennett, Cobb, Jacox, and Jessar, I959) .
Material and methods
Examination of patients was carried out at two centres: the Centre for Rheumatic Diseases, Glasgow, and the Tennent Institute of Ophthalmology, Western Infirmary, Glasgow.
During the years I965 to 1973 any patient seen at the Centre for Rheumatic Diseases with rheumatoid arthritis who had any eye complaint was referred to an ophthalmologist and any case of episcleritis or scleritis was examined in detail. Those patients examined before I97I who were still alive were recalled to hospital or visited in their homes. It was at the beginning of 1971 that a scleritis clinic was instituted at the Tennent Institute, and a pro forma outlined the investigations to be documented for patients at both centres. In all patients these investigations included examination by an ophthalmologist and by a rheumatologist; this was supplemented by laboratory investigations appropriate to ocular inflammation and rheumatoid disease.
The purpose of the study was to compare patients who presented with rheumatoid disease, who subsequently developed episcleritis and scleritis, with patients who presented with episcleritis or scleritis in whom rheumatoid disease was incidental to their referral.
CENTRE FOR RHEUMATIC DISEASES
Between I965 and 1973, 42Io patients with rheumatoid arthritis were examined at the Centre for Rheumatic Diseases. These patients satisfied the diagnostic criteria of the American Rheumatism Association (Ropes and others, 1959) . Seven of these patients had episcleritis and 28 had scleritis. arthritis according to the criteria already cited (Ropes and others, 1959) .
The presentation of results initially gives the incidence of episcleritis and scleritis in rheumatoid arthritis, and also the incidence of rheumatoid arthritis in episcleritis and scleritis. Thereafter, unless it is otherwise indicated, the patients are divided into those with rheumatoid disease and those without rheumatoid disease. This results in four groups of patients with:
i. Rheumatoid episcleritis (nine cases)
2. Rheumatoid scleritis (37 cases) 3. Non-rheumatoid episcleritis (33 cases)
4. Non-rheumatoid scleritis (i8 cases) Comparisons are made between these four groups of patients. In the section dealing with the systemic manifestations of rheumatoid disease and also in some of the laboratory investigations a further comparison is made, that is, between the combined groups of rheumatoid episcleritis and scleritis and a group of rheumatoid controls, patients with rheumatoid arthritis matched for age and sex with the rheumatoid episcleritis/scleritis groups but without episcleral or scleral inflammation. This gives two further groups:
5. Rheumatoid episcleritis/scleritis (46 cases) 6. Rheumatoid controls (46 cases) Statistical analysis is presented throughout the study. However, the numbers, in what is a relatively uncommon type of ocular inflammation, are often very limited. The biological meaning of statistical evidence therefore requires critical appraisal.
OPHTHALMIC EXAMINATION
Complaints of eye symptoms were elicited with as little prompting as possible. The duration of the condition was estimated from the first episode of inflammation. Accurate documentation of duration is difficult as it is not always certain that a condition which may persist intermittently during a period of some years has truly settled. Visual acuity was assessed by Snellen's test chart at the Tennent Institute with or without glasses as appropriate. Refraction was not done routinely.
The anterior segment of each eye was examined in diffuse light, often in ordinary daylight, and by detailed examination with a slit-lamp microscope. Patients seen in their homes were examined with a single loupe and focal light. Slit-lamp examination served to reveal the depth of inflammation, determining which network of vessels was predominantly affected. It is occasionally difficult to be certain whether an apparently nodular episcleritis is in fact a scleritis; the diagnosis is often more readily apparent in retrospect when, for example, an area of scleral translucency will indicate a scleritis. The greyish-blue colour of deep scleritis is due to the dark uvea becoming evident through translucent sclera. In contrast, episcleritis is usually bright red in colour. A careful slit-lamp examination after observation in diffuse light, with a conclusive diagnosis made only after observing the inflammation for varying periods of time, is sufficient in most cases to provide a diagnosis. Nevertheless, there remain a few cases in which it is impossible to differentiate with certainty an episcleritis from a superficial scleritis. The figures that are given, therefore, are not absolute, but the features associated with predominantly superficial inflammation affecting primarily the episclera will be contrasted with features of deeper involvement affecting primarily the sclera.
Ophthalmic examination took note of any corneal complications, anterior uveitis and cataract, particularly posterior subcapsular cataract. The fundi were examined after instillation of cyclopentolate hydrochloride BP I per cent. A Haag-Streit applanation tonometer recorded the intraocular pressure in patients seen in hospital, and a Perkins hand-held applanation tonometer was used for those patients who were visited in their homes.
Any suggestion of limitation of extraocular muscle movement or history of diplopia prompted referral to the orthoptist for a more exact record. All patients were screened for evidence of keratoconjunctivitis sicca (KCS) by Schirmer's tear test (Schirmer I) using standardized filter-paper strips*. The length of wetting of the filter paper at the end of 5 minutes was measured. A normal tear secretion was accepted as I5 mm wetting or more for patients under the age of 40 years, and io mm wetting for patients over the age of 40 years, as standardized by Halberg and Berens (I967). All patients with reduced tear flow had a drop of rose bengal i per cent instilled into the eye, and punctate staining indicated the presence of dead or dying cells and excess mucus. Confirmation of KCS was given by Schirmer's test (Schirmer II) in which a io per cent ammonia solution is held approximately 15-2 cm below the nose to stimulate tear production, which is recorded as in Schirmer I. GENERAL 
EXAMINATION
The following investigations were designed to measure the severity of any disease of the locomotor system, and complications of rheumatoid arthritis and other connective-tissue disorders.
For each patient were recorded four grades of functional incapacity (Steinbrocker, Traeger, and Batterman, I949) . The articular index, a summation index, estimated the number of involved joints and the severity of their involvement as judged by tenderness to pressure over the joint margin. Radiological evidence of the degree of bone involvement was categorized in four stages of increasing severity (Steinbrocker and others, I949) .
A number of extra-articular complications of rheumatoid disease were noted: subcutaneous granulomatous nodules, peripheral neuropathy, vasculitis manifest as skin ulceration or bruising, and tendon rupture. Atrophy of skin was recorded as a recognized sideeffect of treatment with systemic corticosteroids (Scarborough and Shuster, 1960; Greenwood, I966 ).
An enlarged spleen suggested the possibility of Felty's syndrome (Felty, 1924) , and evidence of amyloidosis was noted, as rheumatoid arthritis is now the commonest cause of secondary amyloidosis in western countries (Boyle and Buchanan, 197I) .
Xerostomia and salivary gland enlargement were recorded as features associated with Sj6gren's syndrome (Sj6gren, 1933 An electrocardiogram was used in most patients (unless bedridden and visited at home) to exclude cardiac disease, which has been noted as a complication in patients with scleritis and rheumatoid arthritis (Smoleroff, 1943; Jayson and Jones, I97I) . Blood pressure recordings and cardiac auscultation screened patients for aortic incompetence, which has been associated with scleritis (Pitkeathly, Howitt, and Lyne, I970) .
All patients had a chest x-ray examination to exclude evidence of active tuberculosis or sarcoidosis and to demonstrate any pulmonary complication of rheumatoid arthritis. LABORATORY METHODS In each patient the haemoglobin concentration, erythrocyte sedimentation rate, and serum proteins, although nonspecific in nature, reflected the severity of disease. Haemoglobin estimation at the Tennent Institute of Ophthalmology was given as a percentage, but in the Centre for Rheumatic Diseases it was given in grams per ioo ml. For comparison of data each haemoglobin value in g/Ioo ml was converted to a percentage reading, taking 14 gIo00 ml as a value of ioo per cent. Alkaline phosphatase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase were recorded to assess any association of liver disease and scleritis. Liver disease has been noted in 6 per cent of patients with Sjogren's syndrome without rheumatoid arthritis and in I-5 per cent of patients with Sj6gren's syndrome and rheumatoid arthritis (Whaley, Williamson, Dick, Goudie, Nuki, and . Serum uric acid levels were estimated to exclude gout. In view of the relevance of scleritis in venereal disease, usually syphilis (Cleobury, i826; von Arlt, I885; Holloway and Fry, 1931) (Woods and Guyton, I944;  Hewson, I964), has been incriminated in a case of scleritis (Thomas, Helluy, Cordier, and Algan, I953) and to exclude it the complement-fixation, standard agglutination (direct), and antihuman globulin (Coombs') tests were performed. Cat, Marinoni, Giraldi, and Costa (I97I) reported that two of their cases of juvenile rheumatoid arthritis had high false positive titres for toxoplasmosis, and accordingly the toxoplasma dye test (Sabin and Feldman, 1948) was routinely investigated.
A multiplicity of autoantibodies may occur in the connective-tissue (collagen) disorders (Copeman, I964) . Scleritis has been called a collagen disorder (Hayreh and Watson, 1970) . In view of this, autoantibody screening tests were undertaken in each case. Tests were carried out for rheumatoid factor, using the latex agglutination technique (Hyland Laboratories) (Ziff, Brown, Lospalluto, Badin, and McEwan, 1956) , the R3 latex agglutination test (Denver Laboratories) using sera giving a positive result in the rheumatoid latex test, and by the tanned red-cell haemagglutination technique for thyroglobulin antibody (Fulthorpe, Roitt, Doniach, and Couchman, I96I) . All the remaining autoantibody investigations applied the indirect immunofluorescent technique. These were tests for thyroid microsomal antibody, antinuclear factor, salivary duct antibody, mitochondrial antibody, gastric parietal-cell antibody, and smooth-muscle antibody (Table I) .
The assay of complement C3 (ic/ia globulin) used specific immunodiffusion plates (Hyland Laboratories) and serum concentrations of IgG, IgA, and IgM globulins were similarly measured by radial immunodiffusion using commercially-prepared plates (Behringwerke) according to the method of Mancini, Carbonara, and Heremans (I965 Lyne and Pitkeathly (1968) with J. W. Kerr and J. M. MacLeod noted that, in 25 of 33 cases having single attacks of episcleritis, the inflammation affected the interpalpebral area. The findings in this present study endorse their report and it seemed worth considering external aggravating factors in the category of immediate hypersensitivity. Altogether 23 patients, all of them with non-rheumatoid inflammation, and all except six cases of episcleritis, were subjected to skin testing for house dust, grass pollen, altemaria, feathers, house dust mite, Aspergillus, Candida albicans; and cat and dog hair, if one of these pets was in the home. (Ropes and others, 1959) . Each of these cases was sero-positive for rheumatoid factor. One further case of episcleritis and six further cases of scleritis were weakly sero-positive for rheumatoid factor, but had no clinical or radiological evidence of rheumatoid arthritis.
(Unless otherwise indicated in the remaining data patients from both clinics with rheumatoid arthritis are combined and compared with the findings of patients without rheumatoid arthritis.) AGE, SEX, AND BILATERALITY (Tables IIIa-f) The only group of patients with a mean age outside the sixth decade was the non-rheumatoid episcleritis group which had a mean value of 45 1 years.
All cases with rheumatoid episcleritis were female and this was consistent with the higher incidence of rheumatoid arthritis in women. Scleritis was found in twice as many women as men (67'6 to 32-4 per cent). It is interesting to note that of the non-rheumatoid patients, episcleritis was found equally in women and men (48-5 and 5I 5 per cent), but scleritis showed a marked preponderance in women (83-3 to i6'7 per cent).
The 9 patients with rheumatoid episcleritis (Tables IVa, b) A breakdown of medical history and associated disease revealed a high incidence of associated abnormality of the cardiovascular and respiratory systems.
Of 30 cases with rheumatoid scleritis (6o0o per cent) in whom electrocardiograms were taken, i8 had ischaemic heart disease. Three further patients complained of angina pectoris but had normal tracings. Six patients with non-rheumatoid episcleritis (21 9 per cent) had electrocardiographic changes and one further patient had a possible pericarditis. Three patients with non-rheumatoid scleritis (I6'7 per cent) had ischaemia of the myocardium. There is a significant difference between the incidence of ischaemia in rheumatoid scleritis and that in non-rheumatoid scleritis (P=o00005). The combined episcleritis/scleritis groups showed a total incidence of myocardial ischaemia in 21 of 37 statistically insignificant difference between these two groups might well be misleading.
Excluding respiratory complaints such as bronchitis, emphysema and asthma, pleurisy and rheumatoid pneumonia, pleural effusion, pleurisy and rheumatoid nodules of the lung, both rheumatoid episcleritis and scleritis had a similar incidence Redness and ocular pain are by far the commonest complaints in both episcleritis and scleritis. A red eye was referred to only slightly less often in rheu- The predominant corneal complication is a sclerosing keratitis which is usually localized at the site nearest to the inflamed sclera or episclera. Occasionally, in diffuse inflammation, the condition is annular (Fig. 4) (Table XII) The findings as regards the development of cataract in patients with rheumatoid scleritis who had (Watson and Lobascher, I965) . Two eyes showed old foci of choroiditis and one eye, in a patient now deceased, optic atrophy of obscure origin, although the eye had been grossly inflamed and suffered a subsequent perforating keratolysis. It was interesting to find oedema of the optic nerve head in one case, suggesting a possible ischaemic optic neuropathy. One patient had an old detached retina.
There was an area of old choroiditis in one case diagnosed as non-rheumatoid episcleritis (i-9 per cent of 52 eyes). Two eyes with non-rheumatoid scleritis had a possibly significant abnormality of the posterior pole (8-o per cent of 25 eyes); in both cases these were areas of macular disturbance.
There was a marked difference in the incidence of abnormality between rheumatoid episcleritis and scleritis. The significant difference between posterior segment complications in rheumatoid scleritis and non-rheumatoid scleritis (P=o0o5) may reflect more severe disease in the rheumatoid patient.
INTRAOCULAR PRESSURE (Tables XIVa, b) One patient with rheumatoid episcleritis had bilateral raised intraocular pressure, but this was Only one patient with non-rheumatoid episcleritis had one eye with a tension fractionally above normal at 22 mmHg, a percentage of i 9 per cent. Seven eyes with non-rheumatoid scleritis had raised levels but in two cases (four eyes) the level of pressure fell from 30 mmHg (right) + 28 mmHg (left) and 30 mmHg (right) + 34 nmmHg (left) to within normal limits on withdrawing topical steroid treatment. It is considered that these were cases of steroid-induced glaucoma. The remaining three cases (I2o per cent) include one patient in whom the intraocular pressure was 38 mmHg. In each case the highest reading recorded is given.
Only one patient, a woman with unilateral rheumatoid scleritis, required a drainage procedure to control her intraocular pressure. There was no flare-up of her scleritis. One patient with a pressure at 22 mmHg in one eye is still receiving miotic treatment. The intraocular pressure of the remaining patients all settled coincident with the quietening of their inflammation, including those patients in whom pressures were recorded in the 30-38 mmHg range.
OCULAR MOVEMENTS (Tables XVa, b) No patient with rheumatoid episcleritis had evidence of muscle imbalance. Eight eyes with rheumatoid scleritis (12-9 per cent) showed limitation of movement of one extraocular muscle or more. Two cases, however, were based on a history of transient diplopia, suggesting tendon or muscle involvement consistent with the site of scleral inflammation. The limitation of movement in the remaining six cases was substantiated by orthoptic examination.
Three cases of non-rheumatoid episcleritis (5 7 per cent) suggested possible tendon and/or muscle The mean value of the albumin/globulin ratio in rheumatoid episcleritis was o88 while that for rheumatoid scleritis was I103. There was a high percentage of reversed ratios in both rheumatoid episcleritis (66-7 per cent) and scleritis (62-2 per cent). Non-rheumatoid patients with episcleritis showed a mean value of I-75 and those with scleritis a mean value of I-53. The difference between these two figures is significant (P=o0o5).
Neither of the groups with non-rheumatoid inflammation had any patient with a reversed ratio. There was a highly significant difference between rheumatoid and non-rheumatoid episcleritis (P=o-ooi) and rheumatoid and non-rheumatoid scleritis (P = o-oo i). The mean value of the albumin/globulin ratio in the rheumatoid episcleritis/scleritis group (i -o) was more abnormal than the group of rheumatoid controls (I i2), but the difference was not statistically significant. Consistent with these findings, the number of patients with a reversed albumin/globulin ratio was greater in the combined episcleritis/ scleritis group (63-o per cent) than in the rheumatoid control group (47.5 per cent).
None of the mean values in all six groups studied is outside the normal range for alkaline phosphatase of 5-I5 King Armstrong units, although it is interesting to note that the mean value for rheumatoid scleritis is at the upper limit of normal, and also that IO of 37 cases with rheumatoid scleritis (27-o per cent) had raised readings. Further, it is noteworthy that there is a statistically significant difference between the levels for rheumatoid episcleritis and non-rheumatoid episcleritis (P=O ooi) and between rheumatoid scleritis and non-rheumatoid scleritis (P = o0o5).
As with alkaline phosphatase, none of the mean values for serum uric acid levels in the six groups of patients investigated was outside the normal range.
A similar pattern emerged for SGOT and SGPT, where all mean values recorded were within normal limits.
WASSERMANN REACTION; VDRL SLIDE TEST, AND REITER PROTEIN COMPLEMENT-FIXATION TEST
The following data relate only to those patients with eye inflammation, both rheumatoid and nonrheumatoid. Seven of the patients with rheumatoid episcleritis and 28 of the patients with rheumatoid scleritis had these investigations and no patient gave a positive result. All the patients with nonrheumatoid episcleritis and with non-rheumatoid scleritis gave similarly negative results.
ANTISTREPTOLYSIN-O TITRE (ASO); BRUCELLOSIS AND TOXOPLASMOSIS
The following data relate only to those patients with rheumatoid episcleritis and scleritis, and nonrheumatoid episcleritis and scleritis. (Tables XXa, b) . It is interesting to note that 8-6 per cent of the patients with rheumatoid episcleritis or rheumatoid scleritis had a titre of I/256 or more. The group with non-rheumatoid episcleritis and non-rheumatoid scleritis showed only one in the same range (I/1024), 2-0 per cent. It is probable that in the normal adult population the incidence of antibodies at a titre of 1/256 is not more than I1O per cent (Beattie, 1958; Ludlam and Beattie, I963) .
AUTOANTIBODIES (Tables XXIa, b)
The following results refer only to those patients with rheumatoid and non-rheumatoid eye inflam- Normal values are given with Table XXIIIa with non-rheumatoid scleritis was a carrier of Stayhylococcus albus. No case in the series had any virus cultured from the conjunctiva.
Two patients with non-rheumatoid episcleritis had fungi isolated from the conjunctiva, in both cases the Penicillium species. Two patients with rheumatoid scleritis had fungi present, in one case Penicillium and in one Aspergillus. One further case with non-rheurnatoid scleritis produced a fungus of the Paecilomyces species.
MORTALITY (Tables XXIV and XXV)
The following data relate to those patients with rheumatoid episcleritis and rheumatoid scleritis, Watson (1974) , and Lyne (1974) , are the sum total of reviews. The incidence of scleritis in rheumatoid arthritis in the study presented has some similarity with the majority of reports previously documented (Table XXVII) . Jayson and Jones (I971) in a group of I42 patients had a notably dissimilar figure and Sevel's estimate of one case of scleritis in 3000 patients with rheumatoid arthritis is much lower than our own conclusions. As with the review of Jayson and Jones (I971) this present series was a prospective study for incidence. The incidence of episcleritis in patients presenting with rheumatoid arthritis has not been documented elsewhere, which is understandable as the condition is relatively uncommon, at least in so far as presentation is concerned. Only seven patients, an average of approximately one for each year of the study, are included in this group. (Slocumb, 1953) , has been -instrumental in initiating a greater frequency of scleritis. Systemic corticosteroids were first used in the treatment of rheumatoid arthritis in I949 (Hench, Kendall, Slocumb, and Polly, 1949) and in the treatment of scleritis in 195I (Talkov, Colpoys, Davis, Papper, and Fienberg, 1951) .
The only reports giving the mean age of patients with scleritis in rheumatoid arthritis are those of Sevel (I966) , and Jayson and Jones (I97i). The nine patients of Jayson and Jones had a mean age of 56-5 years, which is similar to the figure given here (Table IIIa) (Table HId) , together with the finding that one-third of these patients had a weakly positive rheumatoid factor (one was a man), gives some concern for the future of these patients. An unusual connective-tissue disorder seen in the present study, in a 45-year-old man with rheumatoid scleritis, presented with widespread granulomas of orbits, nasal septum, sinuses, and lungs, which had occurred intermittently for more than Io years. The clinical picture was less severe than that of a true Wegener's disease, and lacked the glomerulonephritis typically present in this disease (Godman and Churg, 1954 (Sevel, I965; Watson, 1966) . No previous paper gives episcleritis as a complication of chronic discoid lupus erythematosus.
In the late nineteenth and early twentieth century, gout was considered to be an important cause of ocular inflammation, but the association in most cases of episcleritis or scleritis is vague and indefinite (Duke-Elder and Leigh, I965). During this century reports of episcleritis have been recorded by Gilbert (1914) , Savin (1938), and McWilliams (I952) . In recent years only Watson and Lobascher (1965) reported one case with an episcleritis. Two male patients with gout were seen in the present study; one with non-rheumatoid episcleritis and one with a non-rheumatoid necrotizing scleritis. The necrotizing element developed some weeks after the onset of scleritis, and might have been iatrogenic in origin. The patient had a diffuse scleritis which progressed to develop widespread scleral translucency in the upper half of the anterior sclera. A subconjunctival injection in the upper and lower fornices was followed by an area of necrosis above (Fig. 3) . The eye subsequently settled satisfactorily. Subconjunctival injections of atropine have been incriminated in the aetiology of scleritis (Tooker, 1931; Swan and Butler, 195I One of the cases of episcleritis, which was bilateral, had associated bilateral sclerosing keratitis. It is uncertain why many patients with rheumatoid episcleritis and rheumatoid scleritis had a marked increase in electrocardiographic abnormalities (Table IVa) . It is possible that the changes, which include bundle-branch block myocardial infarction, and non-specific S-T wave changes, might have been in part, at least, due to rheumatoid involvement of the heart, but without necropsy it is impossible to differentiate between rheumatoid disease, induced ischaemia, and other causes of ischaemic heart disease (Hart, I969). Pitkeathly, Howitt, and Lyne (1970) (Jayson and Jones, 1971) . In one male patient in this study with diffuse rheumatoid scleritis aortic stenosis and incompetence were discovered post mortem. One with rheumatoid episcleritis had aortic stenosis and one with non-rheumatoid scleritis had aortic incompetence. None of these patients had a history of rheumatic fever. According to Sokoloff (I972) rheumatoid disease may occasionally cause a valvulitis with incompetence (Van Valkenburgh, Georges, and Irby, I972). Pericarditis has been described in association with rheumatoid arthritis and scleritis (Smoleroff, I943; Edstrom and Osterlind, 1948; Jayson and Jones, 197I (Noonan, Taylor, and Engleman, I963) . This significant finding of pulmonary disease in patients with rheumatoid eye inflammation as compared with rheumatoid controls, together with the possibility of greater cardiac involvement, emphasizes the serious nature of extra-articular rheumatoid disease affecting vital structures with the probable final seal of significance in the higher incidence of mortality in patients so affected.
There is an increasing appreciation of the association of ocular inflammation and joint disorders in patients with inflammatory bowel disease. Wright, Lumsden, Luntz, Sevel, and Truelove (I965) found that I I8 per cent of I44 patients with ulcerative colitis had iritis, and 17A4 per cent had sacro-iliac joint abnormalities. Billson, de Dombal, Watkinson, and Goligher (1967) substantiated the association of eye inflammation and ulcerative colitis, and Jayson, Salmon, and Harrison (1970) found that 50 per cent of patients with ankylosing spondylitis and colitis had an anterior uveitis. Lyne and Pitkeathly (I968) reported two patients with ulcerative colitis associated with scleritis, but without any connective-tissue disorder. 'Watson (I966) described one case of regional ileitis associated with episcleritis, and Hopkins, Horan, Burton, Clamp, de Dombal, and Goligher (1974) recorded two patients with episcleritis associated with regional ileitis. One patient in the present study with rheumatoid episcleritis had recurrent colitis, and one with rheumatoid scleritis had diverticulosis; both were women. The patient with recurrent colitis had an associated anterior uveitis; the patient with diverticulosis had a particularly severe bilateral scleritis with sclerosing keratitis, anterior uveitis, and secondary glaucoma in one eye. However, while it is reported that patients with ulcerative colitis and uveitis have a threefold increase in peripheral joint disease (Wright and Watkinson, I965; McEwen, I968) the arthritis is regarded in most instances as distinct from rheumatoid arthritis. It has been called arthritic ulcerative colitis (Ruhl and Sokoloff, I965) and colitic arthritis or acute toxic arthritis (Fernandez-Herlihy, 1959) . Regional ileitis (Crohn's disease) exhibits the same type of peripheral arthritis (Ferguson, 1972) . This form of arthritis was first described by Hench (I935) . It begins abruptly and reaches its height of intensity within the first day or so, involving the small joints of hands or feet less often than does rheumatoid arthritis (Wright and Watkinson, I965) .
It has been suggested that peptic ulceration occurs more commonly in rheumatoid arthritis (Atwater, Mongan, Wieche, and Jacox, I965; Bowen, Mayne, Caine, and Bartholomew, I960; Meltzer, Bockman, Kanenson, and Cohen, 1958), but both are such common diseases that it is unwise to be dogmatic. Four of our patients with rheumatoid scleritis had peptic ulceration and three of the I I known to have died since examination had gastrointestinal haemorrhage recorded on their death certificates. If the association is valid, is it caused by a vasculitis or is it a therapeutic consequence of, for example, salicylates? Certainly all three patients who died of gastrointestinal haemorrhage had been receiving salicylates. Against this it is noteworthy that four patients with non-rheumatoid episcleritis, that is without severe disease, also had a history of peptic ulceration.
Skin diseases reported with episcleritis are eczema (Watson and Lobascher, I965), contact dermatitis and acne rosacea (Watson, I966) , psoriasis, lichen planus, and erythema elevatum diutinum (Lyne and Pitkeathly, I968) ; and with scleritis, epidermolysis bullosa dystrophica (Mazza and Panagis, I967) . Erythema nodosum, which has already been discussed, has been associated with both episcleritis and scleritis. Psoriasis was evident in two women in the study, one with rheumatoid scleritis and one with non-rheumatoid episcleritis. There were no secondary eye complications in either of the patients with psoriasis. A further patient with non-rheumatoid episcleritis had a history of pityriasis rosea.
Reviewing the literature of scleritis in rheumatoid arthritis, Sevel (I966) found that the condition was more often bilateral. The ratio of 2:I agrees with the findings given here (Table IIIe) . In his own series of II enucleated eyes, the disease was unilateral in eight, an inconsistency which Sevel was unable to explain. Extra-articular manifestations of rheumatoid disease are significantly apparent in this present study and the fact that in most cases rheumatoid scleritis is bilateral reflects the widespread nature of extra-articular involvement. Non-rheumatoid scleritis was more often unilateral and whether or not these patients will later develop autoimmune disease, it seems that they have a more localized disorder. Non-rheumatoid episcleritis in contrast was more often bilateral (Table IIIf) and characteristically recurrent, with inflammation alternating from one eye to the other.
It is generally recognized that the symptoms of episcleritis are less distressing than those of scleritis (Watson and Lobascher, I965; Jayson and Jones, 1971) . One of the objects of this presentation was to provide evidence that these accepted differences do exist. Ocular pain was more apparent in scleritis. The patients complained of a red eye more often in both rheumatoid and non-rheumatoid episcleritis than did those with scleritis (Tables Va, b) . A distinctive finding was the higher incidence of complaints of redness and pain in non-rheumatoid inflammation. Perhaps the rheumatoid patient suffers to such a degree elsewhere that the spontaneous complaint of a red and painful eye is not always given. However, Jones and Jayson (1973) pointed out that the fewer complaints in patients with rheumatoid eye inflammation might be due to the many anti-inflammatory drugs which these patients were receiving, or possibly the higher pain threshold which has been described in rheumatoid arthritis (Huskisson and Hart, 1972) . In his early description of 'sclerotitis', Mackenzie (I830) reported that a number of patients described their eyes as hot and dry at the onset of an episode of inflammation. It was interesting to discover a few patients in this study who said that a dry, gritty, or burning eye would often precede the flare-up of inflammation.
It was surprising to find that the history of eye inflammation was slightly longer in the nonrheumatoid group of patients, both for episcleritis and scleritis (Table VIb) . A simple explanation might be the problem of recollection. Many patients were examined early in the disease, but not all. With so many physical disabilities in what is generally severe rheumatoid disease, the rheumatoid patient might simply have misjudged how long the eye trouble had lasted. Lyne and Pitkeathly (I968) gave a mean duration for all forms of episcleritis of 20 months and a mean duration for all forms of scleritis of 6o months. The difficulty is knowing when an eye is truly quiet and will remain so. Many patients in this study had quiescent periods between inflammation lasting many months, and in one case seven years. Nevertheless, a rather uneasy impression given by the rheumatoid patients is of the disease 'burning out' after two or three years.
As expected, the deeper inflammation of scleritis has a more significant effect on visual acuity (Table  VII) . The study of visual acuity was confined to patients presenting at the Tennent Institute of Ophthalmology as cases of episcleritis or scleritis, and did not include patients presenting with rheumatoid arthritis at the Centre for Rheumatic Diseases. Visual acuity in these patients was affected mainly by anterior segment disease, particularly corneal inflammation and cataract. The review of posterior subcapsular cataract/advanced cataract in rheumatoid patients with scleritis who were receiving systemic corticosteroids also suggests, although without supporting figures, a severe effect on visual acuity (Table XII) . Furthermore, the group of patients with rheumatoid scleritis who had a posterior segment abnormality would have some disturbance of vision (Table XIIIa) . Fortunately, a cataract can readily be extracted and this should provide some reassurance to the clinician who considers that treatment with systemic corticosteroids is imperative. The male patient who developed gout, and subsequently scleritis, recorded a visual acuity which dropped from 6/6-2 to 6/i8-i in four weeks, due to the development of a variable myopic astigmatism. This eventually settled coincident with quiescence of his scleritis as a mixed astigmatism which, on refraction, gave a visual acuity of 6/5, a reminder that reduction in vision might have had a very simple solution.
The abundance of terms used to describe episcleritis and scleritis requires a new simplicity of approach, and this was provided by the classification of Watson, Hayreh, and Awdry (I968a, b) , which was used in this study (Tables VIIIa, b) . Clearly the pathological activity in scleritis and nodular episcleritis has the same basis (Manschot, I96I; Sevel, I967) , and it only remains to give a description of the appearance of any inflammation. There has been much confusion regarding the terms 'scleromalacia' and 'scleromalacia perforans' (Van der Hoeve, 1934) . 'Scleromalacia' is often used for a diffuse scleritis with scleral translucency, but this is not the eye which is the most likely to perforate, and so confusion results. According to the literature the eye which commonly perforates has a typically necrotizing sclera, and the inflammation is necrotic and the sclera opaque but not translucent (Fig. 3) (I964) reported cases where scleral translucency with alarming progressive ectasia necessitated surgical intervention. In these cases there was no necrosis or ulceration.
The importance of these observations is the appreciation that areas of scleral translucency only rarely give cause for concern. Rheumatoid nodule of the sclera was the term used by Ashton and Hobbs (I952) to describe the scleritis found in rheumatoid arthritis. It gives an accurate description of the granulomatous reaction, similar to that found in the subcutaneous nodule of rheumatoid arthritis. However, a sub-division of the lesions into nodular, diffuse, or necrotizing scleritis provides a clear and simple picture of the scleral reaction with the premise that the inflammation is granulomatous. The overall descriptive term for scleritis which satisfies the pathological uniformity of the condition is necrogranulomatous scleritis (Sevel, i967) . It is interesting that none of our cases of rheumatoid episcleritis was nodular in character, whereas in non-rheumatoid episcleritis nearly one-fifth of cases were nodular (Tables VIIIa, b) . Two cases of rheumatoid inflammation initially diagnosed as nodular episcleritis both progressed to a scleritis. Only one patient in the study presented with a necrotizing scleritis. A 63-year-old man developed a non-rheumatoid gouty scleritis, but the necrotizing lesion discussed earlier was probably induced by a subconjunctival steroid injection. DukeElder and Leigh (i965) described the possibility of recurrent nodular episcleritis causing the circumcomeal region of the sclera eventually to become slate-coloured. We submit that any appearance of this nature is due to involvement of the sclera and is no longer an episcleritis but a scleritis. The two patients diagnosed initially as having nodular rheumatoid episcleritis subsequently had a distinct slate-coloured zone at the site of inflammation, and were therefore cases of scleritis. Transparency of the sclera which may accompany scleritis is often described as scleral thinning. This description may create apprehension in the mind of the clinician, and a term such as scleral translucency is preferable. In a recent presentation involving one of us (DDMM), ultrasonographic assessment of the thickness of areas of post-scleritic scleral translucency showed that these areas were not invariably associated with thinning. Only three of eight patients had distinct evidence of thinning of sclera (Rooney, McGavin, Sutherland, and Railton, 1974) . The presence of translucency of the sclera reflects the depth and extent of the scleral inflammation, which in this study was very much more evident in rheumatoid scleritis, indicating that scleritis in rheumatoid disease is generally more severe (Tables VIlla, b) . Posterior scleritis is more common in patients with rheumatoid arthritis which also suggests a more extensive inflammation in rheumatoid disease. Inflammation of the posterior sclera is deduced from its secondary effects on neighbouring tissues. Posterior inflammation resulted in choroiditis in two patients, retinal detachment in one, and extraocular muscle imbalance in five. In a paper on the clinical manifestations of scleritis, Watson (I974) found that of 217 eyes with episcleritis, 170 had the simple variety and 47 had nodular episcleritis. Of 30I eyes with scleritis, I I9 had diffuse anterior scleritis, 134 had nodular anterior scleritis, 42 showed necrotizing scleritis, and six revealed features of a posterior scleritis. This series, easily the largest general study of episcleritis and scleritis, is particularly significant for its record of the clinical features of these conditions.
Lyne and Pitkeathly (I968) noted that single attacks of episcleritis affected the interpalpebral area in 25 of 33 cases. This distribution of inflammation is substantiated by the present study (Tables IXa, b ). Lyne and Pitkeathly suggested that minor trauma might account for this distribution and found a foreign body in one case. Certainly external factors would seem to play a part, whether trauma or some other factor or factors. Patients sometimes complain of a dry, gritty, and burning eye and epiphora was seldom a problem. An eye which is inflamed primarily deep to the conjunctiva may slightly increase in temperature. Evaporation of tears may ensue more rapidly in consequence and so irritation due to exposure will affect the interpalpebral area preferentially. However, this could account only for aggravation of an already inflamed area. It was thought that type I allergy (atopy) might play a part in the external aggravation of an episcleritis. However, in the present study no increase in atopic disease could be found in 23 patients with non-rheumatoid eye inflammation, I7 of whom had episcleritis. Inflammation affecting the anterior sclera in rheumatoid arthritis affects the upper half of the sclera more often than the lower half (Jayson and Jones, 197I) , and Sevel's review of the literature confirms this view. Sevel (1965) in his iI cases examined histologically, found that i8-o per cent had disease of the posterior segment, and his investigation of the literature with regard to eyes enucleated because of scleritis gave a figure of izvo per cent. These figures are not dissimilar to our own for rheumatoid scleritis (Table VIIIa) . However, the distribution of anterior scleritis in this report, although more often affecting the superior aspect of the sclera, does not have the considerable emphasis of Sevel's cases (Table IXa) . Jayson and Jones (I 970I) in their group of 14 patients found a distribution similar to that seen in our study.
Corneal complications in scleral inflammation have been described for over a century (Mackenzie, I830) . The predominant disturbance is a sclerosing keratitis which, according to Watson, Hayreh, and Awdry (I968a), occurs in nearly half of those patients with scleritis but seldom in those with episcieritis. In i i cases which were enucleated and comprised the series of rheumatoid scleritis (Sevel, I965) , 36-o per cent had some form of keratitis. However, rheumatoid episcleritis and rheumatoid scleritis in this investigation showed a high incidence of corneal complications (Table Xa) , in particular sclerosing keratitis (Fig. 4) , and it was interesting to find that anterior uveitis although less common had a similar incidence in rheumatoid episcleritis and rheumatoid scleritis, unexpected findings as regards episcleritis. The anticipated difference between episcleritis and scleritis was confirmed in regard to cataract, glaucoma, and posterior segment disease, but it will be recalled that only 13 eyes had rheumatoid episcleritis. Corneal ulceration occurred in two forms; limbal guttering (Fig. 5) , which has been called marginal furrows (Brown and Grayson, I968) (Tables XIa, b) . Iridocyclitis has often been described with scleritis (Wolfe, i882; Kiehle, 1946; Duke-Elder and Leigh, I965) . Sevel Hurd, Snyder, and Ziff, 1970) , macular oedema (Watson and Lobascher, I965) , retinal striations (Sears, I964) and optic disc oedema (Bertelsen, I960) . Orbital myositis is an extraocular manifestation (Gorduren, I962; Maria, I956) . In his pathological series, Sevel (I965) found choroiditis (64-0 per cent), choroidoretinitis (9-0 per cent) and retinal detachment (64-0 per cent). Rheumatoid scleritis provides disturbing indications of deepseated inflammation, posterior segment abnormality affecting nearly one-third of the patients (Table XIIIa) . Although macular disturbance could have other causes, such as drug-induced maculopathy, senile degeneration (Bedell, 1950; Favre, I960) and vascular disease (Norn, I96I) it is recognized that it may occur with retinitis (Manschot and Von Winning, I953) or iridocyclitis (Samuels, 1930;  Wolff, I93I). It is possible, therefore, that the large number of rheumatoid patients with a macular disturbance may be attributed, in part at least, to the consequence of severe scleritis, the incidence being higher than in the non-rheumatoid patients with scleritis, both groups having a mean age in the sixth decade. The uveitis accompanying a scleritis is more often an anterior uveitis, but whether anterior or posterior it is from this serious complication that most of the consequent ocular problems arise, problems which affect vision -such as cataract, glaucoma, exudative retinal detachment, and macular disturbance. Optic nerve disease after scleritis has had little documentation. Bertelsen (I960) described I2 patients with a posterior scleritis and two of these had oedema of the optic nerve head. The cases of Gorduren (I962) and Maria (1956) (Tables XVa, b ). There is a close association of scleritis, in particular posterior scleritis, with tenonitis, myositis, and pseudotumour formation. (Although orbital myositis has been called a form of pseudotumour the differentiation in terms seems more appropriate.) It is sometimes difficult to reach the correct diagnosis in these conditions. The patient presents with pain, limitation of ocular movement, chemosis, and sometimes lid oedema. The indirect consequence of inflammation provides the clue to diagnosis, and this appearance will often simulate orbital cellulitis. Bertelsen (I960) confesses to this mistake in six of his 12 patients with sclerotenonitis and orbital myositis. Both Gorduren (I962) and Maria (1956) The incidence of Sj6gren's syndrome in rheumatoid arthritis has been estimated at between 9 and 34 per cent, and in the sicca syndrome there is a 6o to 75 per cent incidence of connectivetissue disease (Henkind and Gold, 1973) . Talal (1972) considers that keratoconjunctivitis sicca develops in I o to I 5 per cent of patients with rheumatoid arthritis and cites the report of Stenstam (I947). While the incidence of keratoconjunctivitis sicca in the present study in patients with rheumatoid episcleritis and rheumatoid scleritis falls within the accepted range for rheumatoid arthritis, the incidence of Sjogren's syndrome is considerably higher than that found by in patients with rheumatoid arthritis, also attending the Centre for Rheumatic Diseases. He found that between 6 and 7 per cent of patients with rheumatoid arthritis had Sj6gren's syndrome. The incidence given here in rheumatoid episcleritis (33.3 per cent) and rheumatoid scleritis (32z4 per cent) reflects the extent of extra-articular manifestations in patients with rheumatoid episcleral and scleral inflammation.
RHEUMATOLOGY
It is not the purpose of this paper to discuss the rheumatological findings in any detail. However, some of the results of this aspect of our study lead us to suspect that the underlying disease of scleritis in these patients may be a vasculitis.
The arthritis in patients with rheumatoid episcleritis and rheumatoid scleritis was of longer duration and revealed more severe erosive changes on x-ray examination as compared with the rheumatoid controls (Table XVII) . On the other hand, the functional capacity and the degree of joint tenderness were similar in the rheumatoid patients with and without inflammatory eye disease. Subcutaneous nodules in rheumatoid arthritis are found in approximately one-third of patients (Boyle and Buchanan, 1971) . Of the patients with rheumatoid episcleritis and rheumatoid scleritis 50 per cent had subcutaneous nodules, twice the percentage found in the control group of patients (Table  XVIII) . Histological studies of early nodule formation by Sikoloff, McCluskey, and Bunim (1953) suggest that the nodule develops around an inflamed blood vessel. It is significant that biopsy of episcleral nodules in patients with rheumatoid arthritis has given a pathological picture similar to that of the subcutaneous nodule of rheumatoid arthritis (Edstrom and Osterlind, 1948 (Ferguson and Slocumb, I96I) . It is interesting that while respiratory disease and possibly cardiac involvement were features notable in the patients with rheumatoid eye inflammation, renal disease was not a problem. Rheumatoid vasculitis affects the peripheral nerves (Hart, Golding, and McKenzie, 1957; Ferguson and Slocumb, I96I; Wilkinson and Torrance, I967), giving rise to a sensory and/or motor neuropathy (Hart and Golding, I960; Schmid and others, I96I) and to dermal infarction (Bywaters, 1957; Golding, Hamil- ton, and Gill, I965). In the group of patients with rheumatoid episcleritis and rheumatoid scleritis, 8-9 per cent had a peripheral neuropathy, presumably due to vasculitis affecting the vasa nervorum, and i3'3 per cent had skin ulcers, both incidences very much higher than expected, although for these numbers there was no statistically significant increase in the incidence of peripheral neuropathy or skin ulcers as compared with that in rheumatoid controls (Table XVIII) .
Many patients with rheumatoid scleritis also manifested skin bruising and skin atrophy (Table   XVIII) , features almost certainly attributable to systemic corticosteroid treatment, which most of the patients were receiving (Boyle and Buchanan, 1971) . It has been suggested that systemic corticosteroids produce alteration in the dermal connective tissue, particularly in collagen (Scarborough and Schuster, I960; Greenwood, I966) .
Patients with rheumatoid ocular inflammation also had a high incidence of splenomegaly (i0o9 per cent) (Table XVIII) . All five patients with splenomegaly had anaemia and two of the patients had a neutropenia. The syndrome of chronic rheumatoid arthritis, splenomegaly, and neutropenia, first described by Felty (1924) , is said to occur in fewer than 5 per cent of patients with rheumatoid arthritis (Walker and Wright, I968).
The picture that emerges in the patient with rheumatoid episcleritis and rheumatoid scleritis is that of long-standing rheumatoid disease and severe erosive joint changes on x-ray examination, with many extra-articular manifestations of rheumatoid disease, many of which reflect an underlying rheumatoid vasculitis. Episcleritis and scleritis in these patients is further evidence of widespread and severe disease affecting eyes, peripheral nerves, skin, lungs, and possibly the heart. These findings substantiate the reports of Jones and Jayson (I973), who found a significant incidence of rheumatoid subcutaneous nodules and other features of microvasculitis in patients with rheumatoid scleritis. LABORATORY 
INVESTIGATIONS
Laboratory data confirm the expected evidence of widespread disorder in patients with rheumatoid disease as compared with patients with nonrheumatoid eye inflammation. A significant difference was noted in the findings comparing rheumatoid and non-rheumatoid patients as regards haemoglobin and albumin/globulin ratio. The erythrocyte sedimentation rate was measured by two different methods but the readings in patients with rheumatoid disease were clearly far higher (Tables XIXa, b) . It is interesting to note that the mean values for haemoglobin, erythrocyte sedimentation rate, and albumin/globulin ratio were all more abnormal in the patients with rheumatoid episcleritis and rheumatoid scleritis than in the rheumatoid control group, although only the findings for the erythrocyte sedimentation rate were statistically significant ( Table XIXc) .
The normal adult range for positive titres to Toxoplasma gondii is in the region of 30 to 40 per cent. Only the small group of patients with rheumatoid episcleritis had a figure that was very much higher (Table XXa) . Beattie (1958) (Broughton, 1970) , pregnancy (Purtilo, Hallgren, and Yunis, I972) and where a choroidoretinitis due to toxoplasmosis may relapse and toxoplasma antibody levels rise (Beattie, 1958) . These are conditions associated with impaired cellmediated immunity, and there is recent evidence of depression of cell-mediated immunity in some patients with rheumatoid arthritis (Waxman, Lockshin, Schnapp, and Doneson, 1973) .
The titre of rheumatoid factor reflects the severity of the disease (Ziff, 1957; Kellgren and Ball, 1959) and the consequent prognosis (Duthie, Brown, Truelove, Barager, and Lawrie, I964 Pollak, I964) and it is known that the prevalence and titre of antinuclear factor is highest in patients with severe arthritis (Hall, Bardawil, Bayles, Mednis, and Galins, I960), vascular and granulomatous complications and Felty's syndrome (Alexander, Bremner, and MacSween, 1973) and gastric parietal-cell antibody, in which a general population study of hospital inpatients older than 50 years gave a figure of io per cent with the higher figure of I3 6 per cent in women (Anderson, Buchanan, and Goudie, I967) .
MacSween (I973) in his group of II4 control patients in a study of primary biliary cirrhosis found an incidence of I0 per cent in women and 5 per cent in men.
The complement system consists of a group of serum proteins which amplify the effects of some antigen-antibody interactions (Austen, 1972) . In rheumatoid arthritis, serum complement levels have been found to be normal or slightly raised I959) and also reduced (Mongan, Cass, Jacox, and Vaughan, I969; Weinstein, Peters, Brown, and Bluestone, I972) . Six rheumatoid patients in this study show reduced values (Table XXIIIa) and it may be that hypocomplementaemia reflects active vasculitis, as has been shown previously in rheumatoid arthritis (Mongan, Cass, Jacox, and Vaughan, I969; Weinstein and others, 1972) . Six of the patients with non-rheumatoid eye inflammation also had serum complement levels below ioo mg/IOO ml (Table XXIIIb) and it is difficult to suggest causes of this finding. One of these patients gave a history of gout and essential hypertension, and another had erythema nodosa. However, it should be noted that there is some dubiety as to what is the range of normal for serum complement readings. The normal mean value in this study was taken as 145 mg/IOO ml (+22 mg/10o ml) (Shanbrom, Khoo, and Lou, 1967) . Thompson (1972) found a mean value of ii8 mg/ioo ml (+26 mg/ioo ml) in 66 healthy individuals.
Immunoglobulins IgG, IgA, and IgM show little variation from normal figures in either rheumatoid or non-rheumatoid eye inflammation.
MORTALITY
The mortality in rheumatoid patients with episcleral and scleral inflammation was soberingly high, 45.5 per cent (Table XXIV) . Fifteen of 33 known cases of rheumatoid episcleritis or rheumatoid scleritis had died since examination, compared with six of 33 known rheumatoid control patients (i8-2 per cent). A decreased life expectancy has been observed in rheumatoid arthritis (Reah, I963) and the outlook and severity of the condition is always more grave in sero-positive disease (Duthie and others, I964). Jones (Johansson, I967) . This finding in a small series suggests that any external factor which might predispose to the interpalpebral distribution of inflammation found in many patients with episcleritis (Lyne and Pitkeathly, I968) (Table  IXb) does not have its origin in a susceptibility to atopic disease.
In a recent publication reviewing ocular manifestations of rheumatic disorders, Henkind and Gold (1973) 2. All patients with rheumatoid episcleritis, rheumatoid scleritis, and non-rheumatoid scleritis had a mean age in the sixth decade, and the disease was more prevalent in women; whereas patients with non-rheumatoid episcleritis had a mean age in the fifth decade and the disease occurred equally between the sexes. 3. Rheumatoid episcleritis and rheumatoid scleritis were associated with widespread systemic disease, particularly of the cardiovascular and respiratory systems. 4. The most common complaints in episcleritis and scleritis were of redness and pain. Ocular pain was more evident in scleritis. Eye symptoms were more readily noted in non-rheumatoid inflammation. 5. All groups of patients had a very wide range in the duration of intermittent ocular inflammation, from a few days or weeks to I5 years or more. 6. Visual acuity is more severely depressed in scleritis than in episcleritis as a result of the associated ocular complications. 7. In a classification of scleritis as nodular, diffuse, and necrotizing, diffuse scleritis was the most common form in both rheumatoid and non-rheumatoid scleritic inflammation. Posterior scleritis was more common in rheumatoid scleritis than in non-rheumatoid inflammation. Scleral translucency was found considerably more often in rheumatoid than in non-rheumatoid scleritis. 
